Development and validation of a survey instrument for assessing prescribers' perception of computerized drug-drug interaction alerts

被引:18
|
作者
Zheng, Kai [1 ,2 ]
Fear, Kathleen [2 ]
Chaffee, Bruce W. [3 ,4 ]
Zimmerman, Christopher R. [3 ,4 ]
Karls, Edward M. [5 ]
Gatwood, Justin D. [3 ]
Stevenson, James G. [3 ,4 ]
Pearlman, Mark D. [6 ]
机构
[1] Univ Michigan, Dept Hlth Management & Policy, Sch Publ Hlth, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Pharm Serv, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Qual Improvement, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Obstet & Gynecol, Sch Med, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
CLINICAL DECISION-SUPPORT; PHYSICIAN ORDER ENTRY; INFORMATION-TECHNOLOGY; USER ACCEPTANCE; HEALTH-CARE; MEDICATION SAFETY; CONCEPTUAL-MODEL; SYSTEMS; ADOPTION; IMPACT;
D O I
10.1136/amiajnl-2010-000053
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective To develop a theoretically informed and empirically validated survey instrument for assessing prescribers' perception of computerized drug-drug interaction (DDI) alerts. Materials and methods The survey is grounded in the unified theory of acceptance and use of technology and an adapted accident causation model. Development of the instrument was also informed by a review of the extant literature on prescribers' attitude toward computerized medication safety alerts and common prescriber-provided reasons for overriding. To refine and validate the survey, we conducted a two-stage empirical validation study consisting of a pretest with a panel of domain experts followed by a field test among all eligible prescribers at our institution. Results The resulting survey instrument contains 28 questionnaire items assessing six theoretical dimensions: performance expectancy, effort expectancy, social influence, facilitating conditions, perceived fatigue, and perceived use behavior. Satisfactory results were obtained from the field validation; however, a few potential issues were also identified. We analyzed these issues accordingly and the results led to the final survey instrument as well as usage recommendations. Discussion High override rates of computerized medication safety alerts have been a prevalent problem. They are usually caused by, or manifested in, issues of poor end user acceptance. However, standardized research tools for assessing and understanding end users' perception are currently lacking, which inhibits knowledge accumulation and consequently forgoes improvement opportunities. The survey instrument presented in this paper may help fill this methodological gap. Conclusion We developed and empirically validated a survey instrument that may be useful for future research on DDI alerts and other types of computerized medication safety alerts more generally.
引用
收藏
页码:I51 / I61
页数:11
相关论文
共 50 条
  • [21] Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug InteractionsA Postal Survey of US Prescribers
    Yu Ko
    Daniel C. Malone
    Grant H. Skrepnek
    Edward P. Armstrong
    John E. Murphy
    Jacob Abarca
    Rick A. Rehfeld
    Sally J. Reel
    Raymond L. Woosley
    Drug Safety, 2008, 31 : 525 - 536
  • [22] Core Drug-Drug Interaction Alerts for Inclusion in Pediatric Electronic Health Records With Computerized Prescriber Order Entry
    Harper, Marvin B.
    Longhurst, Christopher A.
    McGuire, Troy L.
    Tarrago, Rod
    Desai, Bimal R.
    Patterson, Al
    JOURNAL OF PATIENT SAFETY, 2014, 10 (01) : 59 - 63
  • [23] Are We Heeding the Warning Signs? Examining Providers' Overrides of Computerized Drug-Drug Interaction Alerts in Primary Care
    Slight, Sarah P.
    Seger, Diane L.
    Nanji, Karen C.
    Cho, Insook
    Maniam, Nivethietha
    Dykes, Patricia C.
    Bates, David W.
    PLOS ONE, 2013, 8 (12):
  • [24] Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation
    Meslin, S. M. M.
    Zheng, W. Y.
    Day, R. O.
    Tay, E. M. Y.
    Baysari, M. T.
    APPLIED CLINICAL INFORMATICS, 2018, 9 (04): : 849 - 855
  • [25] Management of Drug-Drug Interaction Alerts for Clinical Decision Support in Outpatients
    Su, Chien Hao
    Hsu, Chien Ning
    Tsai, Shu Chen
    Wang, Yu Chin Lily
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 299 - 299
  • [26] Tiering Drug-Drug Interaction Alerts by Severity Increases Compliance Rates
    Paterno, Marilyn D.
    Maviclia, Saverio M.
    Gorman, Paul N.
    Seger, Diane L.
    Yoshida, Eileen
    Seger, Andrew C.
    Bates, David W.
    Gandhi, Tejal K.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2009, 16 (01) : 40 - 46
  • [27] Comment: Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting
    Horn, John R.
    Hansten, Philip D.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (06) : 826 - 826
  • [28] A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency
    Russ, Alissa L.
    Chen, Siying
    Melton, Brittany L.
    Johnson, Elizabette G.
    Spina, Jeffrey R.
    Weiner, Michael
    Zillich, Alan J.
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2015, 41 (09): : 396 - +
  • [29] Adverse events targeted by drug-drug interaction alerts in hospitalized patients
    Gatenby, James
    Blomqvist, Magnus
    Burke, Rosemary
    Ritchie, Angus
    Gibson, Kathy
    Patanwala, Asad E.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2020, 143 (143)
  • [30] Review of physician adherence to drug-drug interaction alerts in a transplant hospital
    Polidori, P.
    Di Giorgio, C.
    Bavetta, S.
    Carollo, A.
    Patella, C.
    Provenzani, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 208 - 208